scorecard
  1. Home
  2. stock market
  3. news
  4. US stocks edge lower amid earnings reports and a new vaccine hiccup

US stocks edge lower amid earnings reports and a new vaccine hiccup

Matthew Fox   

US stocks edge lower amid earnings reports and a new vaccine hiccup
Stock Market1 min read
  • US stocks slipped on Tuesday as the third-quarter earnings season kicked off.
  • JPMorgan and Citigroup reported quarterly results as investors watched for further signs of stimulus progress.
  • A temporary pause in Johnson & Johnson's COVID-19 vaccine trial spooked investors awaiting a successful vaccine to help stifle the pandemic.
  • Watch major indexes update live here.

US stocks slid on Tuesday as third-quarter earnings season kicked off with reports from banks like JPMorgan and Citigroup.

Major indexes also faced pressure as Johnson & Johnson said it would pause its COVID-19 vaccine trial because of an unexpected illness in a participant. The announcement sent shares lower and dented near-term hopes for a vaccine.

JPMorgan reported better-than-expected earnings, helped partly by a surge in trading revenue that was buoyed by a rise in global stocks. Citigroup also benefited from a jump in trading revenue, helping it to report earnings that beat analysts' expectations.

Here's where US indexes stood shortly after the 9:30 a.m. ET market open on Tuesday:

Read more: MORGAN STANLEY: Buy these 44 cheap stocks poised to surge as the economy continues to recover and reopening expands.

Aside from its vaccine hiccup, Johnson & Johnson also reported earnings that beat analysts' estimates and raised its fiscal 2020 revenue and earnings guidance.

Shares of Disney climbed after it announced it would reorganize its media-and-entertainment business to focus on its streaming ambitions with its Disney Plus service.

Gold fell as much as 1.5%, to $1,893.26 per ounce.

Oil traded higher. West Texas Intermediate crude jumped as much as 2.6%, to $40.44 per barrel. Brent crude, oil's international benchmark, rose 2.3%, to $42.68 per barrel, at intraday highs.

Read more: Morgan Stanley lays out its 5 favorite trades for investors looking to dominate a looming V-shaped recovery, even if a stimulus deal takes until 2021

READ MORE ARTICLES ON


Advertisement

Advertisement